ELIC — Elicera Therapeutics AB Share News
0.000.00%
Last trade - 00:00- SEK199.54m
- SEK141.41m
- SEK10.86m
Brief: Elicera Receives Notice Of Allowance For European Patent
Brief: Elicera Therapeutics Q1 Adj. EPS at SEK -0.11
Brief: Elicera Therapeutics Q4 Oper Loss Widens To SEK 4 Mln
Brief: Elicera Therapeutics Submits Clinical Trial Application
Brief: Elicera Therapeutics Reports Additional Signals Of Clinical Activity In ELC-100 Study
Brief: Elicera Therapeutics Q3 Operating Loss Widens To SEK 7 Million
Founders Receive Additional Grants
Brief: Elicera Therapeutics Enters Collaboration With Spanish Research Institution
Brief: Elicera Therapeutics Q2 Operating Loss Widens To SEK 3.7 Million
Brief: Elicera Therapeutics Receives EU Funding
Brief: Elicera Concludes Preclinical Proof-Of-Concept Studies For Elc-201
Brief: Elicera Therapeutics Q1 Operating Loss Widens To SEK 4.7 Mln
Brief: Elicera Therapeutics Q4 Operating Loss Narrows To SEK 2.14 Mln
Brief: Elicera Therapeutics Secures SEK 5 Million In Funding From Vinnova
Brief: Elicera Therapeutics Acquirer Patent From Immunicum
Brief: Elicera Therapeutics Enters Agreement With Baylor College Of Medicine
Brief: Elicera Q3 Operating Loss Widens To SEK 6.8 Mln
Brief: Elicera Therapeutics Enters Agreement With BionNTech